Edgewise Therapeutics, Inc. (EWTX)
NASDAQ: EWTX · Real-Time Price · USD
42.75
-0.77 (-1.77%)
Aug 10, 2026, 9:40 AM EDT - Market open
Edgewise Therapeutics Stock Forecast
Stock Price Forecast
According to 13 analysts polled by S&P Global, Edgewise Therapeutics stock has a consensus rating of "Buy" and an average price target of $50.85. The average 1-year stock price forecast is 18.95% higher than the current stock price, while the lowest is $32 (-25.15%) and the highest is $66 (+54.39%).
Price Target: $50.85 (+18.95%)
Analyst Consensus: Buy
Price Target
ChartAnalyst Ratings
The average analyst rating for Edgewise Therapeutics stock is "Buy". This means that analysts believe this stock is likely to outperform the market over the next twelve months.
Recommendation Trends
| Rating | Feb '26 | Mar '26 | Apr '26 | May '26 | Jun '26 | Jul '26 |
|---|---|---|---|---|---|---|
| Strong Buy | 7 | 7 | 7 | 7 | 7 | 8 |
| Buy | 3 | 3 | 3 | 3 | 2 | 2 |
| Hold | 2 | 2 | 2 | 2 | 2 | 2 |
| Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 12 | 12 | 12 | 12 | 11 | 12 |
Latest Forecasts
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| Evercore ISI | Evercore ISI | Buy Maintains $55 | Buy | Maintains | $55 | +28.65% | Aug 7, 2026 |
| RBC Capital | RBC Capital | Buy Maintains $59 | Buy | Maintains | $59 | +38.01% | Aug 7, 2026 |
| H.C. Wainwright | H.C. Wainwright | Buy Maintains $45 | Buy | Maintains | $45 | +5.26% | Aug 6, 2026 |
| Oppenheimer | Oppenheimer | Buy Initiates $51 | Buy | Initiates | $51 | +19.30% | Jul 9, 2026 |
| Guggenheim | Guggenheim | Buy Maintains $41 → $51 | Buy | Maintains | $41 → $51 | +19.30% | Jul 6, 2026 |
Financial Forecast
Revenue This Year
n/a
Revenue Next Year
58.75M
EPS This Year
-2.14
from -1.63
EPS Next Year
-1.56
from -2.14
EPS and Forward PE are based on non-GAAP adjusted numbers.